fibrinogen has been researched along with Severe Acute Respiratory Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Han, H; Li, J; Liu, F; Liu, R; Liu, XH; Wu, KL; Yang, L; Zhu, CL | 1 |
| Arter, WE; Chevassut, T; Eziefula, AC; Ladikou, EE; Milne, KM; Philips, B; Ramasamy, R; Saad, R; Sivaloganathan, H; Stoneham, SM | 1 |
| Chan, C; Chan, CP; Jin, DY; Siu, KL; Zheng, BJ | 1 |
| Han, M; Hou, J; Luo, X; Ning, Q; Wang, H; Wang, Z; Xi, D; Yan, W; Yao, H | 1 |
| Robertson, M | 1 |
| Gou, CY; Li, XH; Liang, LC; Qi, J | 1 |
1 trial(s) available for fibrinogen and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
[Changes and significance of peripheral blood fibrinogen level in patients with severe acute respiratory syndrome].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Middle Aged; Prognosis; Severe Acute Respiratory Syndrome; Young Adult | 2007 |
5 other study(ies) available for fibrinogen and Severe Acute Respiratory Syndrome
| Article | Year |
|---|---|
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
Topics: Adult; Anticoagulants; Betacoronavirus; Biomarkers; Blood Coagulation; Blood Coagulation Tests; China; Coronavirus Infections; COVID-19; Disease Outbreaks; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral; Prothrombin; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
Topics: Biomarkers; Cohort Studies; Coronavirus Infections; COVID-19; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hospital Mortality; Hospitals, University; Humans; Intensive Care Units; Male; Pandemics; Pneumonia, Viral; Risk Assessment; Sampling Studies; Severe Acute Respiratory Syndrome; Survival Rate; United Kingdom; Venous Thromboembolism; von Willebrand Factor | 2020 |
Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of the human FGL2 gene.
Topics: Cell Line; Coronavirus Nucleocapsid Proteins; Fibrinogen; Humans; Nucleocapsid Proteins; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Transcription, Genetic | 2009 |
Construction of plasmids expressing Sars-CoV encoding proteins and their effects on transcription of hfgl2 prothrombinase.
Topics: Animals; CHO Cells; Coronavirus M Proteins; Coronavirus Nucleocapsid Proteins; Cricetinae; Cricetulus; Fibrinogen; Genetic Vectors; Humans; Membrane Glycoproteins; Nucleocapsid Proteins; Plasmids; Recombinant Proteins; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Thromboplastin; Transcription, Genetic; Transfection; Viral Envelope Proteins; Viral Matrix Proteins | 2009 |
Fgl2: link between hepatitis B and SARS?
Topics: Animals; Fibrinogen; Hepatitis B; Humans; Mice; Severe Acute Respiratory Syndrome; Thromboplastin | 2003 |